The global controlled release drug delivery market size is expected to reach USD 110.13 billion by 2030, registering a CAGR of 10.6% according to this report. The benefits associated with controlled release drug delivery systems such as increased therapeutic efficacy, fewer side effects, and low treatment cost are the factors driving the growth of the market during the forecast period. These technologies offer various benefits over traditional delivery forms. Reduced dosage and dosage frequency, enhanced patient compliance, less gastrointestinal side effects, uniform drug effect, improved drug efficacy and safety, and reduced fluctuation of plasma drug levels are some of the major advantages offered by controlled release technology. ![Global Controlled Release Drug Delivery Market]( "Global Controlled Release Drug Delivery Market")
The presence of multiple in-vivo biological barriers that affect the absorption, bioavailability, and stability of the drug has opened a wide horizon for controlled release drug delivery products. For instance, a controlled release drug delivery system has enabled the delivery of even large and complex molecules such as DNA/RNA, proteins, and polypeptides. Additionally, the rising awareness among healthcare professionals, regarding the advantage of controlled release drug delivery systems over conventional systems is expected to drive the demand for the market in long run.
The rapidly increasing geriatric and pediatric population is one of the major factors impacting the growth of the market. Since a major proportion of prescription non-adherence cases is observed in this age group of the population. Innovations in various drug delivery systems have been providing the geriatric and pediatric populations with easy solutions, which are further propelling the market. Controlled release of drugs allows a reduction in overdose in the elderly population as they can be altered according to the required dosage over a specific period of time.
The presence of multiple in-vivo biological barriers that affect the absorption, bioavailability, and stability of the drug has opened a wide horizon for controlled release drug delivery products. For instance, a controlled release drug delivery system has enabled the delivery of even large and complex molecules such as DNA/RNA, proteins, and polypeptides. Additionally, the rising awareness among healthcare professionals, regarding the advantage of controlled release drug delivery systems over conventional systems is expected to drive the demand for the market in long run.
The rapidly increasing geriatric and pediatric population is one of the major factors impacting the growth of the market. Since a major proportion of prescription non-adherence cases is observed in this age group of the population. Innovations in various drug delivery systems have been providing the geriatric and pediatric populations with easy solutions, which are further propelling the market. Controlled release of drugs allows a reduction in overdose in the elderly population as they can be altered according to the required dosage over a specific period of time.
Controlled Release Drug Delivery Market Report Highlights
- Based on application, oral controlled release systems held the largest share in the market in 2022 owing to increasing usage and ease of convenience offered for the administration of medication
- Targeted drug delivery is poised to be the fastest-growing technology segment during the forecast period owing to its various benefits such as increased therapeutic efficacy coupled with increased safety
- The osmotic delivery segment, based on activation modulation drug delivery systems, is likely to witness the highest CAGR due to its ability to not be affected by various factors, such as pH, food consumption, and gastrointestinal motility
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Technology
1.1.2. Release mechanism
1.1.3. Application
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
1.1.1. Technology
1.1.2. Release mechanism
1.1.3. Application
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology outlook
2.2.2. Release mechanism outlook
2.2.3. Regional outlook
2.3. Competitive Insights
2.2. Segment Outlook
2.2.1. Technology outlook
2.2.2. Release mechanism outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. controlled release drug delivery Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increase in need for controlled release dosage forms for pediatric and geriatric population
3.4.1.2. Increased compliance due to nature of dosage forms
3.4.2. Market restraint analysis
3.4.2.1. Limited amount of controlled release dosage forms is acceptable for usage in pediatric conditions
3.4.2.2. Need for high dose of active pharmaceutical ingredient
3.5. controlled release drug delivery Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increase in need for controlled release dosage forms for pediatric and geriatric population
3.4.1.2. Increased compliance due to nature of dosage forms
3.4.2. Market restraint analysis
3.4.2.1. Limited amount of controlled release dosage forms is acceptable for usage in pediatric conditions
3.4.2.2. Need for high dose of active pharmaceutical ingredient
3.5. controlled release drug delivery Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Global controlled release drug delivery Market: Technology Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Wurster technique
4.1.2. Coacervation
4.1.3. Micro encapsulation
4.1.4. Implants
4.1.5. Transdermal
4.1.6. Targeted delivery
4.1.7. Others (microelectromechanical technology, liposomes)
4.2. Controlled release drug delivery Market Share, 2022 & 2030
4.3. Segment Dashboard
4.4. Global controlled release drug delivery Market by Technology Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Wurster technique
4.5.1.1. Wurster technique controlled release drug delivery market, 2018 - 2030 (USD Million)
4.5.2. Coacervation
4.5.2.1. Coacervation controlled release drug delivery market, 2018 - 2030 (USD Million)
4.5.3. Micro Encapsulation
4.5.3.1. Micro encapsulation controlled release drug delivery market, 2018 - 2030 (USD Million)
4.5.4. Implants
4.5.4.1. Implants controlled release drug delivery market, 2018 - 2030 (USD Million)
4.5.5. Transdermal
4.5.5.1. Transdermal controlled release drug delivery market, 2018 - 2030 (USD Million)
4.5.6. Targeted delivery
4.5.6.1. Targeted delivery controlled release drug delivery market, 2018 - 2030 (USD Million)
4.5.7. Others (microelectromechanical technology, liposomes)
4.5.7.1. Others controlled release drug delivery market, 2018 - 2030 (USD Million)
4.1.1. Wurster technique
4.1.2. Coacervation
4.1.3. Micro encapsulation
4.1.4. Implants
4.1.5. Transdermal
4.1.6. Targeted delivery
4.1.7. Others (microelectromechanical technology, liposomes)
4.2. Controlled release drug delivery Market Share, 2022 & 2030
4.3. Segment Dashboard
4.4. Global controlled release drug delivery Market by Technology Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Wurster technique
4.5.1.1. Wurster technique controlled release drug delivery market, 2018 - 2030 (USD Million)
4.5.2. Coacervation
4.5.2.1. Coacervation controlled release drug delivery market, 2018 - 2030 (USD Million)
4.5.3. Micro Encapsulation
4.5.3.1. Micro encapsulation controlled release drug delivery market, 2018 - 2030 (USD Million)
4.5.4. Implants
4.5.4.1. Implants controlled release drug delivery market, 2018 - 2030 (USD Million)
4.5.5. Transdermal
4.5.5.1. Transdermal controlled release drug delivery market, 2018 - 2030 (USD Million)
4.5.6. Targeted delivery
4.5.6.1. Targeted delivery controlled release drug delivery market, 2018 - 2030 (USD Million)
4.5.7. Others (microelectromechanical technology, liposomes)
4.5.7.1. Others controlled release drug delivery market, 2018 - 2030 (USD Million)
Chapter 5. Global controlled release drug delivery Market: Release Mechanism Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Polymer Based Systems
5.1.2. Micro Reservoir Partition Controlled Drug Delivery Systems
5.1.3. Feedback Regulated Drug Delivery Systems
5.1.4. Activation-modulated Drug Delivery Systems
5.1.4.1. Osmotic Pressure Activated
5.1.4.2. Hydrodynamic Pressure Activated
5.1.4.3. Vapor Pressure Activated
5.1.4.4. Mechanically Activated
5.1.4.5. Magnetically Activated
5.1.5. Chemically Activated
5.1.5.1. pH Activated
5.1.5.2. Hydrolysis Activated
5.1.5.3. Enzyme Activated
5.2. Controlled release drug delivery Market Share, 2022 & 2030
5.3. Segment Dashboard
5.4. Global controlled release drug delivery Market by Release Mechanism Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Polymer based systems
5.5.1.1. Polymer based systems controlled release drug delivery market, 2018 - 2030 (USD Million)
5.5.2. Micro reservoir partition controlled drug delivery systems
5.5.2.1. Micro reservoir partition controlled drug delivery systems market, 2018 - 2030 (USD Million)
5.5.3. Feedback regulated drug delivery systems
5.5.3.1. Feedback regulated drug delivery systems market, 2018 - 2030 (USD Million)
5.5.4. Activation-modulated drug delivery systems
5.5.4.1. Activation-modulated drug delivery systems market, 2018 - 2030 (USD Million)
5.5.4.2. Osmotic pressure activated systems market, 2018 - 2030 (USD Million)
5.5.4.3. Hydrodynamic pressure activated systems market, 2018 - 2030 (USD Million)
5.5.4.4. Vapor pressure activated systems market, 2018 - 2030 (USD Million)
5.5.4.5. Mechanically activated systems market, 2018 - 2030 (USD Million)
5.5.4.6. Magnetically activated systems market, 2018 - 2030 (USD Million)
5.5.5. Chemically activated
5.5.5.1. pH activated controlled release drug delivery market, 2018 - 2030 (USD Million)
5.5.5.2. Hydrolysis activated controlled release drug delivery market, 2018 - 2030 (USD Million)
5.5.5.3. Enzyme activated controlled release drug delivery market, 2018 - 2030 (USD Million)
5.1.1. Polymer Based Systems
5.1.2. Micro Reservoir Partition Controlled Drug Delivery Systems
5.1.3. Feedback Regulated Drug Delivery Systems
5.1.4. Activation-modulated Drug Delivery Systems
5.1.4.1. Osmotic Pressure Activated
5.1.4.2. Hydrodynamic Pressure Activated
5.1.4.3. Vapor Pressure Activated
5.1.4.4. Mechanically Activated
5.1.4.5. Magnetically Activated
5.1.5. Chemically Activated
5.1.5.1. pH Activated
5.1.5.2. Hydrolysis Activated
5.1.5.3. Enzyme Activated
5.2. Controlled release drug delivery Market Share, 2022 & 2030
5.3. Segment Dashboard
5.4. Global controlled release drug delivery Market by Release Mechanism Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Polymer based systems
5.5.1.1. Polymer based systems controlled release drug delivery market, 2018 - 2030 (USD Million)
5.5.2. Micro reservoir partition controlled drug delivery systems
5.5.2.1. Micro reservoir partition controlled drug delivery systems market, 2018 - 2030 (USD Million)
5.5.3. Feedback regulated drug delivery systems
5.5.3.1. Feedback regulated drug delivery systems market, 2018 - 2030 (USD Million)
5.5.4. Activation-modulated drug delivery systems
5.5.4.1. Activation-modulated drug delivery systems market, 2018 - 2030 (USD Million)
5.5.4.2. Osmotic pressure activated systems market, 2018 - 2030 (USD Million)
5.5.4.3. Hydrodynamic pressure activated systems market, 2018 - 2030 (USD Million)
5.5.4.4. Vapor pressure activated systems market, 2018 - 2030 (USD Million)
5.5.4.5. Mechanically activated systems market, 2018 - 2030 (USD Million)
5.5.4.6. Magnetically activated systems market, 2018 - 2030 (USD Million)
5.5.5. Chemically activated
5.5.5.1. pH activated controlled release drug delivery market, 2018 - 2030 (USD Million)
5.5.5.2. Hydrolysis activated controlled release drug delivery market, 2018 - 2030 (USD Million)
5.5.5.3. Enzyme activated controlled release drug delivery market, 2018 - 2030 (USD Million)
Chapter 6. Global controlled release drug delivery Market: Application Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Metered Dose Inhalers
6.1.2. Injectable
6.1.3. Transdermal and Ocular Patches
6.1.4. Infusion Pumps
6.1.5. Oral Controlled-drug delivery Systems
6.1.6. Drug Eluting Stents
6.2. controlled release drug delivery Market Share, 2022 & 2030
6.3. Segment Dashboard
6.4. Global controlled release drug delivery Market by Application Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Metered dose inhalers
6.5.1.1. Metered dose inhaler controlled release drug delivery market, 2018 - 2030 (USD Million)
6.5.2. Injectable
6.5.2.1. Injectable controlled release drug delivery market, 2018 - 2030 (USD Million)
6.5.3. Transdermal and ocular patches
6.5.3.1. Transdermal and ocular patches controlled release drug delivery market, 2018 - 2030 (USD Million)
6.5.4. Infusion Pumps
6.5.4.1. Infusion pumps controlled release drug delivery market, 2018 - 2030 (USD Million)
6.5.5. Oral controlled release drug delivery system
6.5.5.1. Oral controlled release drug delivery market, 2018 - 2030 (USD Million)
6.5.6. Drug eluting stents
6.5.6.1. Drug eluting stents controlled release drug delivery market, 2018 - 2030 (USD Million)
6.1.1. Metered Dose Inhalers
6.1.2. Injectable
6.1.3. Transdermal and Ocular Patches
6.1.4. Infusion Pumps
6.1.5. Oral Controlled-drug delivery Systems
6.1.6. Drug Eluting Stents
6.2. controlled release drug delivery Market Share, 2022 & 2030
6.3. Segment Dashboard
6.4. Global controlled release drug delivery Market by Application Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Metered dose inhalers
6.5.1.1. Metered dose inhaler controlled release drug delivery market, 2018 - 2030 (USD Million)
6.5.2. Injectable
6.5.2.1. Injectable controlled release drug delivery market, 2018 - 2030 (USD Million)
6.5.3. Transdermal and ocular patches
6.5.3.1. Transdermal and ocular patches controlled release drug delivery market, 2018 - 2030 (USD Million)
6.5.4. Infusion Pumps
6.5.4.1. Infusion pumps controlled release drug delivery market, 2018 - 2030 (USD Million)
6.5.5. Oral controlled release drug delivery system
6.5.5.1. Oral controlled release drug delivery market, 2018 - 2030 (USD Million)
6.5.6. Drug eluting stents
6.5.6.1. Drug eluting stents controlled release drug delivery market, 2018 - 2030 (USD Million)
Chapter 7. Global controlled release drug delivery Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2022 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2022
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
7.7. North America
7.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.7.2. U.S.
7.7.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.7.3. Canada
7.7.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.8. Europe
7.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.8.2. UK
7.8.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.8.3. Germany
7.8.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.8.4. France
7.8.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.8.5. Italy
7.8.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.8.6. Spain
7.8.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.8.7. Russia
7.8.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.8.8. Switzerland
7.8.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.8.9. The Netherland
7.8.9.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.8.10. Sweden
7.8.10.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.8.11. Belgium
7.8.11.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.8.12. Others
7.8.12.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.9. Asia Pacific
7.9.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.9.2. Japan
7.9.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.9.3. China
7.9.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.9.4. India
7.9.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.9.5. South Korea
7.9.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.9.6. Thailand
7.9.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.9.7. Indonesia
7.9.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.9.8. Philippines
7.9.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.9.9. Vietnam
7.9.9.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.9.10. Malaysia
7.9.10.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.9.11. Singapore
7.9.11.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.9.12. Others
7.9.12.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.10. Latin America
7.10.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.10.2. Brazil
7.10.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.10.3. Mexico
7.10.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.10.4. Argentina
7.10.4.7. Market estimates and forecast, 2018 - 2030 (USD Million)
7.10.5. Colombia
7.10.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.10.6. Chile
7.10.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.10.7. Others
7.10.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.11. MEA
7.11.1. South Africa
7.11.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.11.2. Saudi Arabia
7.11.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.11.3. UAE
7.11.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.11.4. Kuwait
7.11.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.11.5. Israel
7.11.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.11.6. Others
7.11.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2022
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
7.7. North America
7.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.7.2. U.S.
7.7.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.7.3. Canada
7.7.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.8. Europe
7.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.8.2. UK
7.8.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.8.3. Germany
7.8.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.8.4. France
7.8.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.8.5. Italy
7.8.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.8.6. Spain
7.8.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.8.7. Russia
7.8.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.8.8. Switzerland
7.8.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.8.9. The Netherland
7.8.9.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.8.10. Sweden
7.8.10.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.8.11. Belgium
7.8.11.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.8.12. Others
7.8.12.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.9. Asia Pacific
7.9.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.9.2. Japan
7.9.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.9.3. China
7.9.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.9.4. India
7.9.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.9.5. South Korea
7.9.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.9.6. Thailand
7.9.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.9.7. Indonesia
7.9.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.9.8. Philippines
7.9.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.9.9. Vietnam
7.9.9.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.9.10. Malaysia
7.9.10.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.9.11. Singapore
7.9.11.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.9.12. Others
7.9.12.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.10. Latin America
7.10.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.10.2. Brazil
7.10.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.10.3. Mexico
7.10.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.10.4. Argentina
7.10.4.7. Market estimates and forecast, 2018 - 2030 (USD Million)
7.10.5. Colombia
7.10.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.10.6. Chile
7.10.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.10.7. Others
7.10.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.11. MEA
7.11.1. South Africa
7.11.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.11.2. Saudi Arabia
7.11.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.11.3. UAE
7.11.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.11.4. Kuwait
7.11.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.11.5. Israel
7.11.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.11.6. Others
7.11.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.2.2. Market Leaders
8.2.3. Emerging Players
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2022
8.4. Public Companies
8.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
8.4.2. Company market share/ranking, by region
8.4.3. Competitive dashboard analysis
8.4.3.1. Market differentiators
8.4.3.2. Synergy analysis: major deals and strategic alliances
8.5. Private Companies
8.5.1. List of key emerging company’s/technology disruptors/innovators
8.5.2. Funding outlook
8.5.3. Regional network map
8.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
8.5.5. Supplier ranking
8.5.6. Key company profiled
8.5.7. Depomed, Inc.
8.5.7.1. Company overview
8.5.7.2. Financial performance
8.5.7.3. Product benchmarking
8.5.7.4. Strategic initiatives
8.5.8. Coating Place, Inc.
8.5.8.1. Company overview
8.5.8.2. Financial performance
8.5.8.3. Product benchmarking
8.5.8.4. Strategic initiatives
8.5.9. Corium International, Inc.
8.5.9.1. Company overview
8.5.9.2. Financial performance
8.5.9.3. Product benchmarking
8.5.9.4. Strategic initiatives
8.5.10. Johnson and Johnson Services, Inc.
8.5.10.1. Company overview
8.5.10.2. Financial performance
8.5.10.3. Product benchmarking
8.5.10.4. Strategic Initiative
8.5.11. Alkermes plc
8.5.11.1. Company overview
8.5.11.2. Financial performance
8.5.11.3. Product benchmarking
8.5.11.4. Strategic initiatives
8.5.12. Pfizer, Inc.
8.5.12.1. Company overview
8.5.12.2. Financial performance
8.5.12.3. Product benchmarking
8.5.12.4. Strategic initiatives
8.5.13. Orbis Biosciences, Inc.
8.5.13.1. Company overview
8.5.13.2. Financial performance
8.5.13.3. Product benchmarking
8.5.13.4. Strategic initiatives
8.5.14. Capsugel
8.5.14.1. Company overview
8.5.14.2. Financial performance
8.5.14.3. Product benchmarking
8.5.14.4. Strategic initiatives
8.5.15. Merck and Co., Inc.
8.5.15.1. Company overview
8.5.15.2. Financial performance
8.5.15.3. Product benchmarking
8.5.15.4. Strategic initiatives
8.5.16. Aradigm Corporation
8.5.16.1. Company overview
8.5.16.2. Financial performance
8.5.16.3. Product benchmarking
8.5.16.4. Strategic initiatives
8.2. Company/Competition Categorization
8.2.1. Innovators
8.2.2. Market Leaders
8.2.3. Emerging Players
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2022
8.4. Public Companies
8.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
8.4.2. Company market share/ranking, by region
8.4.3. Competitive dashboard analysis
8.4.3.1. Market differentiators
8.4.3.2. Synergy analysis: major deals and strategic alliances
8.5. Private Companies
8.5.1. List of key emerging company’s/technology disruptors/innovators
8.5.2. Funding outlook
8.5.3. Regional network map
8.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
8.5.5. Supplier ranking
8.5.6. Key company profiled
8.5.7. Depomed, Inc.
8.5.7.1. Company overview
8.5.7.2. Financial performance
8.5.7.3. Product benchmarking
8.5.7.4. Strategic initiatives
8.5.8. Coating Place, Inc.
8.5.8.1. Company overview
8.5.8.2. Financial performance
8.5.8.3. Product benchmarking
8.5.8.4. Strategic initiatives
8.5.9. Corium International, Inc.
8.5.9.1. Company overview
8.5.9.2. Financial performance
8.5.9.3. Product benchmarking
8.5.9.4. Strategic initiatives
8.5.10. Johnson and Johnson Services, Inc.
8.5.10.1. Company overview
8.5.10.2. Financial performance
8.5.10.3. Product benchmarking
8.5.10.4. Strategic Initiative
8.5.11. Alkermes plc
8.5.11.1. Company overview
8.5.11.2. Financial performance
8.5.11.3. Product benchmarking
8.5.11.4. Strategic initiatives
8.5.12. Pfizer, Inc.
8.5.12.1. Company overview
8.5.12.2. Financial performance
8.5.12.3. Product benchmarking
8.5.12.4. Strategic initiatives
8.5.13. Orbis Biosciences, Inc.
8.5.13.1. Company overview
8.5.13.2. Financial performance
8.5.13.3. Product benchmarking
8.5.13.4. Strategic initiatives
8.5.14. Capsugel
8.5.14.1. Company overview
8.5.14.2. Financial performance
8.5.14.3. Product benchmarking
8.5.14.4. Strategic initiatives
8.5.15. Merck and Co., Inc.
8.5.15.1. Company overview
8.5.15.2. Financial performance
8.5.15.3. Product benchmarking
8.5.15.4. Strategic initiatives
8.5.16. Aradigm Corporation
8.5.16.1. Company overview
8.5.16.2. Financial performance
8.5.16.3. Product benchmarking
8.5.16.4. Strategic initiatives
List of Tables
Table 1: List of Abbreviation
Table 2: North America controlled release drug delivery market, by region, 2018-2030 (USD Million)
Table 3: North America controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 4: North America controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 5: North America controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 6: U.S. controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 7: U.S. controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 8: U.S. controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 9: Canada controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 10: Canada controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 11: Canada controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 12: Europe controlled release drug delivery market, by region, 2018-2030 (USD Million)
Table 13: Europe controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 14: Europe controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 15: Europe controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 16: Germany controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 17: Germany controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 18: Germany controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 19: U.K. controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 20: U.K. controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 21: U.K. controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 22: France controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 23: France controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 24: France controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 25: Italy controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 26: Italy controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 27: Italy controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 28: Spain controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 29: Spain controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 30: Spain controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 31: The Netherland controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 32: The Netherland controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 33: The Netherland controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 34: Switzerland controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 35: Switzerland controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 36: Switzerland controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 37: Russia controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 38: Russia controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 39: Russia controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 40: Sweden controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 41: Sweden controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 42: Sweden controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 43: Belgium controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 44: Belgium controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 45: Belgium controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 46: Asia Pacific controlled release drug delivery market, by region, 2018-2030 (USD Million)
Table 47: Asia Pacific controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 48: Asia Pacific controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 49: Asia Pacific controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 50: Japan controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 51: Japan controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 52: Japan controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 53: China controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 54: China controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 55: China controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 56: India controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 57: India controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 58: India controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 59: South Korea controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 60: South Korea controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 61: South Korea controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 62: Thailand controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 63: Thailand controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 64: Thailand controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 65: Indonesia controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 66: Indonesia controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 67: Indonesia controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 68: Philippines controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 69: Philippines controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 70: Philippines controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 71: Vietnam controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 72: Vietnam controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 73: Vietnam controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 74: Singapore controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 75: Singapore controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 76: Singapore controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 77: Malaysia controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 78: Malaysia controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 79: Malaysia controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 80: Latin America controlled release drug delivery market, by region, 2018-2030 (USD Million)
Table 81: Latin America controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 82: Latin America controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 83: Latin America controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 84: Brazil controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 85: Brazil controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 86: Brazil controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 87: Mexico controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 88: Mexico controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 89: Mexico controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 90: Argentina controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 91: Argentina controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 92: Argentina controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 93: Colombia controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 94: Colombia controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 95: Colombia controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 96: Chile controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 97: Chile controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 98: Chile controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 99: Middle east and Africa controlled release drug delivery market, by region, 2018-2030 (USD Million)
Table 100: Middle east and Africa controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 101: Middle east and Africa controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 102: Middle east and Africa controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 103: South Africa controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 104: South Africa controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 105: South Africa controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 106: Saudi Arabia controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 107: Saudi Arabia controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 108: Saudi Arabia controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 109: UAE controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 110: UAE controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 111: UAE controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 112: Kuwait controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 113: Kuwait controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 114: Kuwait controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 115: Israel controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 116: Israel controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 117: Israel controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 2: North America controlled release drug delivery market, by region, 2018-2030 (USD Million)
Table 3: North America controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 4: North America controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 5: North America controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 6: U.S. controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 7: U.S. controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 8: U.S. controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 9: Canada controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 10: Canada controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 11: Canada controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 12: Europe controlled release drug delivery market, by region, 2018-2030 (USD Million)
Table 13: Europe controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 14: Europe controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 15: Europe controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 16: Germany controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 17: Germany controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 18: Germany controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 19: U.K. controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 20: U.K. controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 21: U.K. controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 22: France controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 23: France controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 24: France controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 25: Italy controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 26: Italy controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 27: Italy controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 28: Spain controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 29: Spain controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 30: Spain controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 31: The Netherland controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 32: The Netherland controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 33: The Netherland controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 34: Switzerland controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 35: Switzerland controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 36: Switzerland controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 37: Russia controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 38: Russia controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 39: Russia controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 40: Sweden controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 41: Sweden controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 42: Sweden controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 43: Belgium controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 44: Belgium controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 45: Belgium controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 46: Asia Pacific controlled release drug delivery market, by region, 2018-2030 (USD Million)
Table 47: Asia Pacific controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 48: Asia Pacific controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 49: Asia Pacific controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 50: Japan controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 51: Japan controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 52: Japan controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 53: China controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 54: China controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 55: China controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 56: India controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 57: India controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 58: India controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 59: South Korea controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 60: South Korea controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 61: South Korea controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 62: Thailand controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 63: Thailand controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 64: Thailand controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 65: Indonesia controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 66: Indonesia controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 67: Indonesia controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 68: Philippines controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 69: Philippines controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 70: Philippines controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 71: Vietnam controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 72: Vietnam controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 73: Vietnam controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 74: Singapore controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 75: Singapore controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 76: Singapore controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 77: Malaysia controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 78: Malaysia controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 79: Malaysia controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 80: Latin America controlled release drug delivery market, by region, 2018-2030 (USD Million)
Table 81: Latin America controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 82: Latin America controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 83: Latin America controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 84: Brazil controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 85: Brazil controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 86: Brazil controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 87: Mexico controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 88: Mexico controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 89: Mexico controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 90: Argentina controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 91: Argentina controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 92: Argentina controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 93: Colombia controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 94: Colombia controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 95: Colombia controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 96: Chile controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 97: Chile controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 98: Chile controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 99: Middle east and Africa controlled release drug delivery market, by region, 2018-2030 (USD Million)
Table 100: Middle east and Africa controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 101: Middle east and Africa controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 102: Middle east and Africa controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 103: South Africa controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 104: South Africa controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 105: South Africa controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 106: Saudi Arabia controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 107: Saudi Arabia controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 108: Saudi Arabia controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 109: UAE controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 110: UAE controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 111: UAE controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 112: Kuwait controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 113: Kuwait controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 114: Kuwait controlled release drug delivery market, by application, 2018-2030 (USD Million)
Table 115: Israel controlled release drug delivery market, by technology, 2018-2030 (USD Million)
Table 116: Israel controlled release drug delivery market, by release mechanism, 2018-2030 (USD Million)
Table 117: Israel controlled release drug delivery market, by application, 2018-2030 (USD Million)
List of Figures
Fig. 1: Market research process
Fig. 2: Data triangulation techniques
Fig. 3: Primary research pattern
Fig. 4: Primary interviews in North America
Fig. 5: Primary interviews in Europe
Fig. 6: Primary interviews in APAC
Fig. 7: Primary interviews in Latin America
Fig. 8: Primary interviews in MEA
Fig. 9: Market research approaches
Fig. 10: Value-chain-based sizing & forecasting
Fig. 11: QFD modeling for market share assessment
Fig. 12: Market formulation & validation
Fig. 13: controlled release drug delivery market: market outlook
Fig. 14: controlled release drug delivery market competitive insights
Fig. 15: Parent market outlook
Fig. 16: Related/ancillary market outlook
Fig. 17: Penetration and growth prospect mapping
Fig. 18: Industry value chain analysis
Fig. 19: controlled release drug delivery market driver impact
Fig. 20: controlled release drug delivery market restraint impact
Fig. 21: controlled release drug delivery market strategic initiatives analysis
Fig. 22: controlled release drug delivery market: technology movement analysis
Fig. 23: controlled release drug delivery market: technology outlook and key takeaways
Fig. 24: Wurster technique market estimates and forecast, 2018-2030
Fig. 25: Coacervation market estimates and forecast, 2018-2030
Fig. 26: Micro encapsulation market estimates and forecast, 2018-2030
Fig. 27: Implants market estimates and forecast, 2018-2030
Fig. 28: Transdermal market estimates and forecast, 2018-2030
Fig. 29: Targeted delivery market estimates and forecast, 2018-2030
Fig. 30: Others market estimates and forecast, 2018-2030
Fig. 31: controlled release drug delivery market: release mechanism movement analysis
Fig. 32: controlled release drug delivery market: release mechanism outlook and key takeaways
Fig. 33: Polymer based systems market estimates and forecast, 2018-2030
Fig. 34: Micro reservoir partition-controlled drug delivery systems estimate and forecasts, 2018-2030
Fig. 35: Feedback regulate drug delivery systems estimates and forecasts, 2018-2030
Fig. 36: Activation-modulated drug delivery systems estimates and forecasts, 2018-2030
Fig. 37: Chemically activated drug delivery systems estimates and forecasts, 2018-2030
Fig. 38: controlled release drug delivery market: application movement analysis
Fig. 39: controlled release drug delivery market: application outlook and key takeaways
Fig. 40: Metered dose inhaler market estimates and forecasts, 2018-2030
Fig. 41: Injectable controlled release drug delivery market estimates and forecasts, 2018-2030
Fig. 42: Transdermal and Ocular patches controlled release drug delivery market estimates and forecasts, 2018-2030
Fig. 43: Infusion pumps controlled release drug delivery market estimates and forecasts, 2018-2030
Fig. 44: Oral controlled drug delivery systems market estimates and forecasts, 2018-2030
Fig. 45: Drug eluting stents controlled release drug delivery market estimates and forecasts, 2018-2030
Fig. 46: Global controlled release drug delivery market: regional movement analysis
Fig. 47: Global controlled release drug delivery market: regional outlook and key takeaways
Fig. 48: Global controlled release drug delivery market shares and leading players
Fig. 49: North America market share and leading players
Fig. 50: Europe market share and leading players
Fig. 51: Asia Pacific market share and leading players
Fig. 52: Latin America market share and leading players
Fig. 53: Middle East & Africa market share and leading players
Fig. 54: North America: SWOT
Fig. 55: Europe SWOT
Fig. 56: Asia Pacific SWOT
Fig. 57: Latin America SWOT
Fig. 58: MEA SWOT
Fig. 59: North America, by country
Fig. 60: North America
Fig. 61: North America market estimates and forecasts, 2018-2030
Fig. 62: U.S.
Fig. 63: U.S. market estimates and forecasts, 2018-2030
Fig. 64: Canada
Fig. 65: Canada market estimates and forecasts, 2018-2030
Fig. 66: Europe
Fig. 67: Europe. market estimates and forecasts, 2018-2030
Fig. 68: UK
Fig. 69: UK market estimates and forecasts, 2018-2030
Fig. 70: Germany
Fig. 71: Germany market estimates and forecasts, 2018-2030
Fig. 72: France
Fig. 73: France market estimates and forecasts, 2018-2030
Fig. 74: Italy
Fig. 75: Italy market estimates and forecasts, 2018-2030
Fig. 76: Spain
Fig. 77: Spain market estimates and forecasts, 2018-2030
Fig. 78: Russia
Fig. 79: Russia market estimates and forecasts, 2018-2030
Fig. 80: The Netherlands
Fig. 81: The Netherlands market estimates and forecasts, 2018-2030
Fig. 82: Switzerland
Fig. 83: Switzerland market estimates and forecasts, 2018-2030
Fig. 84: Sweden
Fig. 85: Sweden market estimates and forecasts, 2018-2030
Fig. 86: Belgium
Fig. 87: Belgium market estimates and forecasts, 2018-2030
Fig. 88: Asia Pacific
Fig. 89: Asia Pacific market estimates and forecasts, 2018-2030
Fig. 90: China
Fig. 91: China market estimates and forecasts, 2018-2030
Fig. 92: Japan
Fig. 93: Japan market estimates and forecasts, 2018-2030
Fig. 94: India
Fig. 95: India market estimates and forecasts, 2018-2030
Fig. 96: Thailand
Fig. 97: Thailand market estimates and forecasts, 2018-2030
Fig. 98: South Korea
Fig. 99: South Korea market estimates and forecasts, 2018-2030
Fig. 100: Indonesia
Fig. 101: Indonesia market estimates and forecasts, 2018-2030
Fig. 102: Philippines
Fig. 103: Taiwan market estimates and forecasts, 2018-2030
Fig. 104: Vietnam
Fig. 105: Singapore market estimates and forecasts, 2018-2030
Fig. 106: Singapore
Fig. 107: Australia market estimates and forecasts, 2018-2030
Fig. 108: Malaysia
Fig. 109: Malaysia market estimates and forecasts, 2018-2030
Fig. 110: Latin America
Fig. 111: Latin America market estimates and forecasts, 2018-2030
Fig. 112: Brazil
Fig. 113: Brazil market estimates and forecasts, 2018-2030
Fig. 114: Mexico
Fig. 115: Mexico market estimates and forecasts, 2018-2030
Fig. 116: Argentina
Fig. 117: Argentina market estimates and forecasts, 2018-2030
Fig. 118: Colombia
Fig. 119: Colombia market estimates and forecasts, 2018-2030
Fig. 120: Chile
Fig. 121: Chile market estimates and forecasts, 2018-2030
Fig. 122: Middle East and Africa
Fig. 123: Middle East and Africa. market estimates and forecasts, 2018-2030
Fig. 124: South Africa
Fig. 125: South Africa market estimates and forecasts, 2018-2030
Fig. 126: Saudi Arabia
Fig. 127: Saudi Arabia market estimates and forecasts, 2018-2030
Fig. 128: UAE
Fig. 129: UAE market estimates and forecasts, 2018-2030
Fig. 130: Kuwait
Fig. 131: Kuwait market estimates and forecasts, 2018-2030
Fig. 132: Israel
Fig. 133: Israel market estimates and forecasts, 2018-2030
Fig. 134: Participant categorization- controlled release drug delivery market
Fig. 135: Market share of key market players- controlled release drug delivery market
Fig. 2: Data triangulation techniques
Fig. 3: Primary research pattern
Fig. 4: Primary interviews in North America
Fig. 5: Primary interviews in Europe
Fig. 6: Primary interviews in APAC
Fig. 7: Primary interviews in Latin America
Fig. 8: Primary interviews in MEA
Fig. 9: Market research approaches
Fig. 10: Value-chain-based sizing & forecasting
Fig. 11: QFD modeling for market share assessment
Fig. 12: Market formulation & validation
Fig. 13: controlled release drug delivery market: market outlook
Fig. 14: controlled release drug delivery market competitive insights
Fig. 15: Parent market outlook
Fig. 16: Related/ancillary market outlook
Fig. 17: Penetration and growth prospect mapping
Fig. 18: Industry value chain analysis
Fig. 19: controlled release drug delivery market driver impact
Fig. 20: controlled release drug delivery market restraint impact
Fig. 21: controlled release drug delivery market strategic initiatives analysis
Fig. 22: controlled release drug delivery market: technology movement analysis
Fig. 23: controlled release drug delivery market: technology outlook and key takeaways
Fig. 24: Wurster technique market estimates and forecast, 2018-2030
Fig. 25: Coacervation market estimates and forecast, 2018-2030
Fig. 26: Micro encapsulation market estimates and forecast, 2018-2030
Fig. 27: Implants market estimates and forecast, 2018-2030
Fig. 28: Transdermal market estimates and forecast, 2018-2030
Fig. 29: Targeted delivery market estimates and forecast, 2018-2030
Fig. 30: Others market estimates and forecast, 2018-2030
Fig. 31: controlled release drug delivery market: release mechanism movement analysis
Fig. 32: controlled release drug delivery market: release mechanism outlook and key takeaways
Fig. 33: Polymer based systems market estimates and forecast, 2018-2030
Fig. 34: Micro reservoir partition-controlled drug delivery systems estimate and forecasts, 2018-2030
Fig. 35: Feedback regulate drug delivery systems estimates and forecasts, 2018-2030
Fig. 36: Activation-modulated drug delivery systems estimates and forecasts, 2018-2030
Fig. 37: Chemically activated drug delivery systems estimates and forecasts, 2018-2030
Fig. 38: controlled release drug delivery market: application movement analysis
Fig. 39: controlled release drug delivery market: application outlook and key takeaways
Fig. 40: Metered dose inhaler market estimates and forecasts, 2018-2030
Fig. 41: Injectable controlled release drug delivery market estimates and forecasts, 2018-2030
Fig. 42: Transdermal and Ocular patches controlled release drug delivery market estimates and forecasts, 2018-2030
Fig. 43: Infusion pumps controlled release drug delivery market estimates and forecasts, 2018-2030
Fig. 44: Oral controlled drug delivery systems market estimates and forecasts, 2018-2030
Fig. 45: Drug eluting stents controlled release drug delivery market estimates and forecasts, 2018-2030
Fig. 46: Global controlled release drug delivery market: regional movement analysis
Fig. 47: Global controlled release drug delivery market: regional outlook and key takeaways
Fig. 48: Global controlled release drug delivery market shares and leading players
Fig. 49: North America market share and leading players
Fig. 50: Europe market share and leading players
Fig. 51: Asia Pacific market share and leading players
Fig. 52: Latin America market share and leading players
Fig. 53: Middle East & Africa market share and leading players
Fig. 54: North America: SWOT
Fig. 55: Europe SWOT
Fig. 56: Asia Pacific SWOT
Fig. 57: Latin America SWOT
Fig. 58: MEA SWOT
Fig. 59: North America, by country
Fig. 60: North America
Fig. 61: North America market estimates and forecasts, 2018-2030
Fig. 62: U.S.
Fig. 63: U.S. market estimates and forecasts, 2018-2030
Fig. 64: Canada
Fig. 65: Canada market estimates and forecasts, 2018-2030
Fig. 66: Europe
Fig. 67: Europe. market estimates and forecasts, 2018-2030
Fig. 68: UK
Fig. 69: UK market estimates and forecasts, 2018-2030
Fig. 70: Germany
Fig. 71: Germany market estimates and forecasts, 2018-2030
Fig. 72: France
Fig. 73: France market estimates and forecasts, 2018-2030
Fig. 74: Italy
Fig. 75: Italy market estimates and forecasts, 2018-2030
Fig. 76: Spain
Fig. 77: Spain market estimates and forecasts, 2018-2030
Fig. 78: Russia
Fig. 79: Russia market estimates and forecasts, 2018-2030
Fig. 80: The Netherlands
Fig. 81: The Netherlands market estimates and forecasts, 2018-2030
Fig. 82: Switzerland
Fig. 83: Switzerland market estimates and forecasts, 2018-2030
Fig. 84: Sweden
Fig. 85: Sweden market estimates and forecasts, 2018-2030
Fig. 86: Belgium
Fig. 87: Belgium market estimates and forecasts, 2018-2030
Fig. 88: Asia Pacific
Fig. 89: Asia Pacific market estimates and forecasts, 2018-2030
Fig. 90: China
Fig. 91: China market estimates and forecasts, 2018-2030
Fig. 92: Japan
Fig. 93: Japan market estimates and forecasts, 2018-2030
Fig. 94: India
Fig. 95: India market estimates and forecasts, 2018-2030
Fig. 96: Thailand
Fig. 97: Thailand market estimates and forecasts, 2018-2030
Fig. 98: South Korea
Fig. 99: South Korea market estimates and forecasts, 2018-2030
Fig. 100: Indonesia
Fig. 101: Indonesia market estimates and forecasts, 2018-2030
Fig. 102: Philippines
Fig. 103: Taiwan market estimates and forecasts, 2018-2030
Fig. 104: Vietnam
Fig. 105: Singapore market estimates and forecasts, 2018-2030
Fig. 106: Singapore
Fig. 107: Australia market estimates and forecasts, 2018-2030
Fig. 108: Malaysia
Fig. 109: Malaysia market estimates and forecasts, 2018-2030
Fig. 110: Latin America
Fig. 111: Latin America market estimates and forecasts, 2018-2030
Fig. 112: Brazil
Fig. 113: Brazil market estimates and forecasts, 2018-2030
Fig. 114: Mexico
Fig. 115: Mexico market estimates and forecasts, 2018-2030
Fig. 116: Argentina
Fig. 117: Argentina market estimates and forecasts, 2018-2030
Fig. 118: Colombia
Fig. 119: Colombia market estimates and forecasts, 2018-2030
Fig. 120: Chile
Fig. 121: Chile market estimates and forecasts, 2018-2030
Fig. 122: Middle East and Africa
Fig. 123: Middle East and Africa. market estimates and forecasts, 2018-2030
Fig. 124: South Africa
Fig. 125: South Africa market estimates and forecasts, 2018-2030
Fig. 126: Saudi Arabia
Fig. 127: Saudi Arabia market estimates and forecasts, 2018-2030
Fig. 128: UAE
Fig. 129: UAE market estimates and forecasts, 2018-2030
Fig. 130: Kuwait
Fig. 131: Kuwait market estimates and forecasts, 2018-2030
Fig. 132: Israel
Fig. 133: Israel market estimates and forecasts, 2018-2030
Fig. 134: Participant categorization- controlled release drug delivery market
Fig. 135: Market share of key market players- controlled release drug delivery market
Companies Mentioned
- Depomed, Inc.
- Coating Place, Inc.
- Corium International, Inc.
- Johnson and Johnson Services, Inc.
- Alkermes plc
- Pfizer, Inc.
- Orbis Biosciences, Inc.
- Capsugel
- Merck and Co., Inc.
- Aradigm Corporation
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | June 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 49.46 Billion |
| Forecasted Market Value ( USD | $ 110.13 Billion |
| Compound Annual Growth Rate | 10.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
